191 related articles for article (PubMed ID: 34564032)
21. An iridium (III) complex as potent anticancer agent induces apoptosis and autophagy in B16 cells through inhibition of the AKT/mTOR pathway.
Tang B; Wan D; Wang YJ; Yi QY; Guo BH; Liu YJ
Eur J Med Chem; 2018 Feb; 145():302-314. PubMed ID: 29331753
[TBL] [Abstract][Full Text] [Related]
22. Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer and antibacterial agents to induce both autophagy and apoptosis.
Chen BB; Pan NL; Liao JX; Huang MY; Jiang DC; Wang JJ; Qiu HJ; Chen JX; Li L; Sun J
J Inorg Biochem; 2021 Jun; 219():111450. PubMed ID: 33826973
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of anticancer effect in vitro and in vivo of iridium(III) complexes on gastric carcinoma SGC-7901 cells.
Zhang WY; Wang YJ; Du F; He M; Gu YY; Bai L; Yang LL; Liu YJ
Eur J Med Chem; 2019 Sep; 178():401-416. PubMed ID: 31202128
[TBL] [Abstract][Full Text] [Related]
24. Anticancer mechanism studies of iridium(III) complexes inhibiting osteosarcoma HOS cells proliferation.
Xie FL; Wang Y; Zhu JW; Xu HH; Guo QF; Wu Y; Liu SH
J Inorg Biochem; 2022 Dec; 237():112011. PubMed ID: 36252336
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of iridium(III) complexes on antineoplastic activity against human gastric carcinoma SGC-7901 cells.
Tian L; Zhang Y; Zhang H; Zhou Y; Li W; Yuan Y; Hao J; Yang L; Liu Y
J Biol Inorg Chem; 2021 Sep; 26(6):705-714. PubMed ID: 34448071
[TBL] [Abstract][Full Text] [Related]
26. Liposome as drug delivery system enhance anticancer activity of iridium (III) complex.
Gu Y; Bai L; Zhang Y; Zhang H; Xing D; Tian L; Zhou Y; Hao J; Liu Y
J Liposome Res; 2021 Dec; 31(4):342-355. PubMed ID: 32892672
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, biological evaluation of novel iridium(III) complexes targeting mitochondria toward melanoma B16 cells.
Yuan Y; Zhang Y; Chen J; Huang C; Liu H; Li W; Liang L; Wang Y; Liu Y
Eur J Med Chem; 2023 Feb; 247():115046. PubMed ID: 36577214
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and mitochondria-localized iridium (III) complexes induce cell death through pyroptosis and ferroptosis pathways.
Hu H; Zhang F; Sheng Z; Tian S; Li G; Tang S; Niu Y; Yang J; Liu Y
Eur J Med Chem; 2024 Mar; 268():116295. PubMed ID: 38437750
[TBL] [Abstract][Full Text] [Related]
29. Light activation of iridium(III) complexes driving ROS production and DNA damage enhances anticancer activity in A549 cells.
Li W; Shi C; Wu X; Zhang Y; Liu H; Wang X; Huang C; Liang L; Liu Y
J Inorg Biochem; 2022 Nov; 236():111977. PubMed ID: 36030672
[TBL] [Abstract][Full Text] [Related]
30. Mitochondria-targeted iridium(III) complexes encapsulated in liposome induce cell death through ferroptosis and gasdermin-mediated pyroptosis.
Huang C; Yuan Y; Li G; Tian S; Hu H; Chen J; Liang L; Wang Y; Liu Y
Eur J Med Chem; 2024 Feb; 265():116112. PubMed ID: 38183779
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and biological evaluation of iridium(III) complexes as potential antitumor agents.
Du F; Bai L; He M; Zhang WY; Gu YY; Yin H; Liu YJ
J Inorg Biochem; 2019 Dec; 201():110822. PubMed ID: 31536949
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, Characterization and Anticancer Efficacy Studies of Iridium (III) Polypyridyl Complexes against Colon Cancer HCT116 Cells.
Xie B; Wang Y; Wang D; Xue X; Nie Y
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080200
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, characterization and irradiation enhances anticancer activity of liposome-loaded iridium(III) complexes.
Tian S; Nie Q; Chen H; Liang L; Hu H; Tang S; Yang J; Liu Y; Yin H
J Inorg Biochem; 2024 Jul; 256():112549. PubMed ID: 38579631
[TBL] [Abstract][Full Text] [Related]
34. Iridium (III) complexes induce cervical carcinoma apoptosis via disturbing cellular redox homeostasis disorder and inhibiting PI3K/AKT/mTOR pathway.
Hao J; Liu H; Wang J; Wang X; Huang C; Liang L; Chen J; Wang Y; Liu Y
J Inorg Biochem; 2022 Oct; 235():111946. PubMed ID: 35932758
[TBL] [Abstract][Full Text] [Related]
35. Exploring anticancer efficiency of mitochondria-targeted cyclometalated iridium(III) complexes.
Gu Y; Wen H; Bai L; Zhou Y; Zhang H; Tian L; Zhang Y; Hao J; Liu Y
J Inorg Biochem; 2020 Nov; 212():111215. PubMed ID: 32919250
[TBL] [Abstract][Full Text] [Related]
36. Mitochondria-targeted cyclometalated iridium (III) complexes: Dual induction of A549 cells apoptosis and autophagy.
Chen L; Tang H; Chen W; Wang J; Zhang S; Gao J; Chen Y; Zhu X; Huang Z; Chen J
J Inorg Biochem; 2023 Dec; 249():112397. PubMed ID: 37844533
[TBL] [Abstract][Full Text] [Related]
37. Significant increase of anticancer efficacy in vitro and in vivo of liposome entrapped ruthenium(II) polypyridyl complexes.
Chen Y; Li W; Yang Y; Zhong R; Hu H; Huang C; Chen J; Liang L; Liu Y
Eur J Med Chem; 2023 Sep; 257():115541. PubMed ID: 37295162
[TBL] [Abstract][Full Text] [Related]
38. Identification of two mitochondrial-targeting cyclometalated iridium(III) complexes as potent anti-glioma stem cells agents.
Peng W; Hegazy AM; Jiang N; Chen X; Qi HX; Zhao XD; Pu J; Ye RR; Li RT
J Inorg Biochem; 2020 Feb; 203():110909. PubMed ID: 31689591
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, characterization and anticancer activity in vitro and in vivo evaluation of an iridium (III) polypyridyl complex.
Yi QY; Wan D; Tang B; Wang YJ; Zhang WY; Du F; He M; Liu YJ
Eur J Med Chem; 2018 Feb; 145():338-349. PubMed ID: 29331805
[TBL] [Abstract][Full Text] [Related]
40. Iridium (III) complex-loaded liposomes as a drug delivery system for lung cancer through mitochondrial dysfunction.
Liao C; Xu D; Liu X; Fang Y; Yi J; Li X; Guo B
Int J Nanomedicine; 2018; 13():4417-4431. PubMed ID: 30104875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]